Ken Moonie

Ken started his plant biotech career at Calgene, where he worked in business development and led operations for the Flav Savr tomato. Ken has provided business development, strategic planning and negotiating expertise to many of the world’s leading plant biotechnology, microbial, seed and crop protection companies, advising clients on strategy and the establishment of more than 140 research alliances, technology licenses, joint ventures, mergers and acquisitions valued at more than $1.6 billion. Among the biotech companies that he worked with over his career, Ken assisted 2Blades with licensing the TALEN gene editing platform and with strategic relationships with Corteva, Bayer, and others.